Evaluation of possible neuroprotective effects of virgin coconut oil on aluminum‐induced neurotoxicity in an in vitro Alzheimer's disease model
Open Access
- 21 November 2023
- journal article
- research article
- Published by Wiley in Journal of Applied Toxicology
- Vol. 44 (4) , 609-622
Abstract
Alzheimer's disease (AD) is a progressive neurological disorder that affects various cognitive functions, behavior, and personality. AD is thought to be caused by a combination of genetic and environmental factors, including exposure to aluminum (Al). Virgin coconut oil (VCO) may have potential as a natural neuroprotectant against AD. Aim of this study was to determine neuroprotective effects of VCO on Al‐induced neurotoxicity in an in vitro AD model. SH‐SY5Y cells were initially cultured in normal growth medium and then differentiated by reducing fetal bovine serum content and adding retinoic acid (RA). Later, brain‐derived neurotrophic factor (BDNF) was added along with RA. The differentiation process was completed on the seventh day. Study groups (n = 3) were designed as control group, VCO group, Al group, Al‐VCO group, Alzheimer model (AD) group, AD + Al‐exposed group (AD+Al), AD + VCO applied group (AD + VCO) and AD + Al‐exposed + VCO applied group (AD + Al + VCO). Specific markers of AD (hyperphosphorylated Tau protein, amyloid beta 1–40 peptide, and amyloid precursor protein) were measured in all groups. In addition, oxidative stress parameters (total antioxidant capacity, lipid peroxidase, protein carbonyl, and reactive oxygen species) and neurotransmitter‐related parameters (dopamine, dopamine transporter acetylcholine, and synuclein alpha levels, acetylcholinesterase activity) were measured comparatively in the study groups. VCO reduced amyloid beta and hyperphosphorylated Tau protein levels in the study groups. In addition, oxidative stress levels decreased, and neurotransmitter parameters improved with VCO. Our study shows that VCO may have potential therapeutic effects in Alzheimer's disease and further experiments are needed to determine its efficacy.Keywords
Funding Information
- Türkiye Bilimsel ve Teknolojik Araştırma Kurumu (BIDEB‐118C483)
This publication has 59 references indexed in Scilit:
- The Physiology, Signaling, and Pharmacology of Dopamine ReceptorsPharmacological Reviews, 2011
- Aluminium in the human brainMonatshefte für Chemie - Chemical Monthly, 2010
- Anti-inflammatory, analgesic, and antipyretic activities of virgin coconut oilPharmaceutical Biology, 2009
- Antioxidant capacity and phenolic acids of virgin coconut oilInternational Journal of Food Sciences and Nutrition, 2009
- Mean age-of-onset of familial alzheimer disease caused by presenilin mutations correlates with both increased Aβ42 and decreased Aβ40Human Mutation, 2006
- Virgin coconut oil supplemented diet increases the antioxidant status in ratsFood Chemistry, 2006
- The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer’s disease-like tau phosphorylationBiochemical and Biophysical Research Communications, 2004
- The Cholinergic Hypothesis of Age and Alzheimer’s Disease-Related Cognitive Deficits: Recent Challenges and Their Implications for Novel Drug DevelopmentThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Blockade of the Noradrenaline Carrier Increases Extracellular Dopamine Concentrations in the Prefrontal Cortex: Evidence that Dopamine Is Taken up In Vivo by Noradrenergic TerminalsJournal of Neurochemistry, 1990
- [48] Assay of glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples1981